I received this email today from the Celiac Disease Foundation…
The evidence cannot be denied:
For many, if not most, celiac disease patients, strict adherence to a gluten-free diet is an inadequate treatment for celiac disease.
Because research dollars have been so hard to come by for celiac disease, biomedical researchers are still at the beginning of understanding the short- and long-term implications of the disease. What they have learned, however, is shocking: for many more celiac disease patients than ever previously thought, even strict adherence to a gluten-free diet, while possibly tempering symptoms, does not resolve celiac disease and/or comorbidities associated with celiac disease.
These revelations have only fortified CDF’s commitment to support celiac disease research for FDA-approved treatments and a cure. You are likely aware of iCureCeliac®, our growing and revolutionary patient registry that is fundamentally and positively changing the economics of celiac disease research. We are also proud of an exciting new, strategic initiative, the Young Investigators Award (YIA). We need to keep the pipeline going of talented biomedical researchers committed to celiac disease research. Thanks to a fruitful partnership, CDF has committed $150,000 to fund the North American Society for the Study of Celiac Disease (NASSCD) Young Investigator Award. We are pleased to announce the first YIA winner, Dr. Matthew Shale, a research fellow at Stanford University School of Medicine’s Institute for Immunity, Transplantation and Infection. To understand more about his pioneering research, please watch this video.
It is urgent for our generation, and for generations to come, that we invest right now in cutting edge research to find treatments and a cure for celiac disease. CDF recognizes that urgency and is committed to making well-vetted, strategic research investments. But we cannot do this without you. Please make a tax-deductible donation of $100, $500, or whatever you can afford, to support CDF’s critical research investments, including the Young Investigator Award.
Marilyn G. Geller
Chief Executive Officer
I agree with this. As a Celiac Disease sufferer myself [About Me], I would like to see an effective cure or therapy for all CD sufferers.
Recent Great Deals [more]: